REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 122 filers reported holding REVANCE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.47 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $343,198 | +13.2% | 10,655 | -35.1% | 0.01% | 0.0% |
| Q4 2022 | $303,206 | -7.6% | 16,425 | -2.3% | 0.01% | -40.0% |
| Q1 2022 | $328,000 | -17.6% | 16,814 | +16.0% | 0.02% | -46.4% |
| Q2 2018 | $398,000 | -41.7% | 14,499 | -34.7% | 0.03% | -41.7% |
| Q1 2018 | $683,000 | +179.9% | 22,187 | +225.3% | 0.05% | +77.8% |
| Q4 2017 | $244,000 | +5.6% | 6,820 | -22.2% | 0.03% | -57.1% |
| Q2 2017 | $231,000 | -72.4% | 8,766 | -81.7% | 0.06% | -35.7% |
| Q1 2016 | $838,000 | -2.2% | 48,002 | +91.2% | 0.10% | +30.7% |
| Q4 2015 | $857,000 | -28.5% | 25,100 | -37.7% | 0.08% | -27.2% |
| Q3 2015 | $1,199,000 | +25.4% | 40,300 | +34.8% | 0.10% | -3.7% |
| Q2 2015 | $956,000 | +6.6% | 29,900 | -30.9% | 0.11% | +16.3% |
| Q1 2015 | $897,000 | +198.0% | 43,300 | +143.3% | 0.09% | +73.6% |
| Q4 2014 | $301,000 | – | 17,800 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $42,779,000 | 61.17% |
| Essex Woodlands Management, Inc. | 3,342,047 | $91,739,000 | 21.30% |
| Sio Capital Management, LLC | 101,292 | $2,780,000 | 1.54% |
| Fosun International Ltd | 472,532 | $12,971,000 | 0.66% |
| Rhenman & Partners Asset Management AB | 203,181 | $5,577,000 | 0.57% |
| ArrowMark Colorado Holdings LLC | 1,804,275 | $49,527,000 | 0.46% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 87,355 | $2,398,000 | 0.30% |
| FOX RUN MANAGEMENT, L.L.C. | 18,477 | $507,000 | 0.16% |
| Phoenix Investment Adviser LLC | 2,400 | $66,000 | 0.12% |
| Quinn Opportunity Partners LLC | 33,100 | $909,000 | 0.12% |